Intrexon Establishes First Collaboration with Dedicated Fund
Startup Company to Access ActoBiotics® Platform to Develop Feed Supplement
Intrexon and ZIOPHARM to Develop Immunotherapies for Treatment of Graft-Versus-Host Disease
Companies Form New Collaboration to Pursue Cellular Therapy Approaches to Autoimmune Disorder
Intrexon Strengthens Leadership Team
Corey Huck to Join as Senior Vice President, Head of Food Sector
Fibrocell and Intrexon Provide Regulatory Update for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)